RecruitingPhase 4NCT04657822
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Sponsor: Novartis Pharmaceuticals
Fort Worth, TX · +6 more sites
1 recruiting sickle cell disease studies with a site in Fort Worth, TX.
All trials in Fort Worth, TX · All Sickle Cell Disease trials
Sponsor: Novartis Pharmaceuticals
Fort Worth, TX · +6 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.